Levels of microRNA‑181b and plasminogen activator inhibitor‑1 are associated with hypertensive disorders complicating pregnancy

Experimental and Therapeutic Medicine

Volumn 8, Issue 5, 2014, Pages 1523-1527

  Chen, Yan Shan ^a   Shen, Ling ^a   Mai, Rui Qin ^a   Wang, Ying ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Hypertensive disorders complicating pregnancy; MicroRNA 181b; Plasminogen activator inhibitor 1

Indexed keywords

LIPOFECTAMINE; MICRORNA; MICRORNA 181B; PLASMINOGEN ACTIVATOR INHIBITOR 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHEMOLUMINESCENCE; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; HYPERTENSION; HYPERTENSIVE DISORDER COMPLICATING PREGNANCY; IMMUNOHISTOCHEMISTRY; MATERNAL HYPERTENSION; PREECLAMPSIA; PREGNANCY COMPLICATION; PROTEIN EXPRESSION; PROTEINURIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; WESTERN BLOTTING;

EID: 84907847976     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.1946     Document Type: Article

References (21)

1. Zhou J, Xiao XM and Wu YH: Expression of interferon-γ in decidual natural killer cells from women with hypertensive disorder complicating pregnancy. J Obstet Gynaecol Res 40: 670-676, 2014.
2. Yang L, Wang YL, Liu S, et al: miR-181b promotes cell proliferation and reduces apoptosis by repressing the expression of adenylyl cyclase 9 (AC9) in cervical cancer cells. FEBS Lett 588: 124-130, 2014.
3. Shi L, Cheng Z, Zhang J, et al: hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells. Brain Res 1236: 185-193, 2008.
4. Simone TM, Archambeault J and Higgins PJ: Small molecule targeting of PAI-1 function: a new therapeutic approach for treatment of vascular stenosis. J Mol Genet Med 7: 1000059, 2013.
5. Gomes-Giacoia E, Miyake M, Goodison S and Rosser CJ: Targeting plasminogen activator inhibitor-1 inhibits angiogenesis and tumor growth in a human cancer xenograft model. Mol Cancer Ther 12: 2697-2708, 2013.
6. Boe AE, Eren M, Murphy SB, et al: Plasminogen activator inhibitor-1 antagonist TM5441 attenuates Nω -nitro-L-arginine methyl ester-induced hypertension and vascular senescence. Circulation 128: 2318-2324, 2013.
7. Li LX, Liu YL, Wen JG, et al: Expression and significance of aquaporin 1 in placenta, placental membranes and peritoneum of patients with hypertensive disorder complicating pregnancy. Zhonghua Fu Chan Ke Za Zhi 43: 497-501, 2008 (In Chinese).
8. Salmani D, Purushothaman S, Somashekara SC, et al: Study of structural changes in placenta in pregnancy-induced hypertension. J Nat Sci Biol Med 5: 352-355, 2014.
9. Okawara M, Seki H, Matsuoka K, et al: Examination of the expression of cyclooxygenase-2 in placenta villi from sufferers of pregnancy induced hypertension. Biol Pharm Bull 32: 2053-2056, 2009.
10. Henao-Mejia J, Williams A, Goff LA, et al: The microRNA miR-181 is a critical cellular metabolic rheostat essential for NKT cell ontogenesis and lymphocyte development and homeostasis. Immunity 38: 984-997, 2013.
11. Zhu Y, Wu J, Li S, et al: The function role of miR-181a in chemosensitivity to adriamycin by targeting Bcl-2 in low-invasive breast cancer cells. Cell Physiol Biochem 32: 1225-1237, 2013.
12. Zhai XF, Fang FF, Liu Q, et al: MiR-181a contributes to bufalin-induced apoptosis in PC-3 prostate cancer cells. BMC Complement Altern Med 13: 325, 2013.
13. Wang XF, Shi ZM, Wang XR, et al: MiR-181d acts as a tumor suppressor in glioma by targeting K-ras and Bcl-2. J Cancer Res Clin Oncol 138: 573-584, 2012.
14. Kronski E, Fiori ME, Barbieri O, et al: miR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and -2. Mol Oncol 8: 581-595, 2014.
15. Yan JJ, Zhu XM, Yin GW, et al: Effect of human miR-181a on function of trophoblast cell line HTR-8/SVneo. Zhonghua Lin Chuang Yi Shi Za Zhi (Dian Zi Ban) 7: 136-138, 2013 (In Chinese).
16. Simone TM and Higgins PJ: Low molecular weight antagonists of plasminogen activator inhibitor-1: therapeutic potential in cardiovascular disease. Mol Med Ther 1: 101, 2012.
17. Yang Z, Wan X, Gu Z, et al: Evolution of the mir-181 microRNA family. Comput Biol Med 52: 82-87, 2014.
18. Madonna R and De Caterina R: Cellular and molecular mechanisms of vascular injury in diabetes - part I: pathways of vascular disease in diabetes. Vascul Pharmacol 54: 68-74, 2011.
19. Cawyer C, Horvat D, Leonard D, et al: Hyperglycemia impairs cytotrophoblast function via stress signaling. Am J Obstet Gynecol: May 1, 2014 (Epub ahead of print).
20. Su L, Liu R, Cheng W, et al: Expression patterns of microRNAs in porcine endometrium and their potential roles in embryo implantation and placentation. PLoS One 9: e87867, 2014.
21. Estella C, Herrer I, Moreno-Moya JM, et al: miRNA signature and Dicer requirement during human endometrial stromal decidualization in vitro. PLoS One 7: e41080, 2012.